CC(=O)O[C@@H]1[C@@H](O)C2=C3[C@@]4(C)[C@H](CC(=O)C(C)(C)[C@H]14)[C@]3(O)[C@H](OC(C)=O)[C@@]1(C[C@@H]1C)C2=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?